Legislation
- Title
- Maryland Medical Assistance Program and Health Insurance – Specialty Drugs – Definition
- Sponsored by
- Delegates Kipke, Adams, Anderton, Arikan, Chisholm, Clark, Hornberger, Krebs, Malone, McComas, Metzgar, Morgan, Reilly, Saab, Szeliga, Bagnall, Belcastro, Bhandari, Carr, Charles, Cullison, Hill, Johnson, Kelly, Kerr, R. Lewis, Pena-Melnyk, Pendergrass, Rosenberg, and K. Young
- Status
- Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 614
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Prohibiting the Secretary of Health from considering certain drugs to be specialty drugs for the purposes of providing services under the Maryland Medical Assistance Program; altering the definition of "specialty drug" for the purpose of excluding prescription drugs prescribed to treat certain conditions from the authority of certain insurers, nonprofit health service plans, and health maintenance organizations to require certain drugs be obtained through a certain pharmacy and to provide coverage through a managed care system; etc.
Committees
- Opposite:
- Finance
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-101, 15-118.1 )
(
15-847, 15-847.1 )
Last Updated: 9/22/2020 2:00 PM